By a News Reporter-Staff News Editor at Investment Weekly News -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announced it has retained Stonegate, Inc. ("Stonegate") to provide institutional investor outreach and capital markets advisory for the Company pending regulatory approval.
"Stellar has reached a key point of our business development and immunotherapy research program where we believe we are well positioned to increase our institutional outreach efforts. Our core business of manufacture and supply of KLH protein continues to strengthen our position to negotiate alliances with commercial partners in parallel with their clinical successes. We continue to make breakthroughs in aquaculture science and our immunotherapy program targeting Clostridium difficile ("C. diff") is on track to deliver data midsummer. These achievements coupled with our strong financial position to support our efforts, reinforces my confidence that we have a compelling story to tell," said Frank Oakes, president and chief executive officer of Stellar Biotechnologies. "Stonegate's team has more than a 40-year track record of success connecting growth companies with institutional investors. Their highly focused approach to deliver effective and innovative targeting solutions should help expand our institutional awareness and shareholder base."
Stonegate is a 40-year old research, capital markets advisory and investment banking boutique dedicated to serving the specialized needs of small-cap public companies. Stonegate provides research, sales and trading, corporate finance, strategic advisory and investor relations' services to a select group of clients. They work with the leading institutional investors in the U.S. and Europe who are seeking high quality investment opportunities in the small cap marketplace.
Stonegate will receive a fee of US $5,000 per month for six months through September 30, 2014, with an optional monthly renewal thereafter. The agreement may be cancelled after the initial six-month term upon 10 days written notice.
Keywords for this news article include: Investment and Finance.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC